Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Pericardium Diseases Companies

ID: MRFR/Pharma/3467-HCR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Pericardium diseases companies focus on providing medical solutions for conditions affecting the pericardium, the sac surrounding the heart. These companies contribute to cardiology by offering diagnostic tools, imaging technologies, and treatments for pericarditis and other pericardium-related disorders.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pericardium Diseases Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.56%
2024 Market Size$ 2.6 Billion
2025 Market Size$ 2.74 Billion
2035 Market Size$ 4.71 Billion
Key Players
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
Johnson & Johnson
Stryker Corporation
Baxter International Inc.
Opportunities
  • Emergence of Targeted Therapies
  • Advancements in Medical Technology
  • Rising Awareness and Education Initiatives

Top Industry Leaders in the Pericardium Diseases Market

Pericardium Diseases Key Companies
ย 
Latest Pericardium Diseases Companies Update
Jan 2024

Abbott Laboratories Received FDA approval for their iRhythm Zio XT patch for continuous ambulatory ECG monitoring, potentially aiding in early detection and diagnosis of pericarditis based on characteristic ECG patterns.Partnered with leading cardiology centers to conduct research on new diagnostic tools and minimally invasive treatment techniques for pericardial diseases.

Boston Scientificย Launched their next-generation Pericardial Drainage System featuring improved catheter design and drainage efficiency, enhancing the safety and efficacy of pericardiocentesis procedures.Collaborated with healthcare providers to implement standardized treatment protocols for different types of pericarditis, aiming for improved patient outcomes and reduced complications.

Medtronicย Developed a novel pericardial patch with antimicrobial properties for preventing post-surgical infections and pericarditis recurrence after pericardiectomy procedures.Supported research initiatives investigating the role of genetic factors in the development of certain types of pericarditis, paving the way for personalized preventative strategies.

Mayo Clinicย Conducted a large-scale study identifying specific biomarkers in blood tests that can help differentiate between different causes of pericarditis, enabling more targeted treatment decisions.Established a multidisciplinary Pericardial Disease Center aiming to provide comprehensive care, advance research, and educate healthcare professionals on optimal management of pericardial conditions.

The Pericardial Diseases Foundationย Launched a global awareness campaign educating the public about the signs and symptoms of pericarditis, encouraging early diagnosis, and dispelling myths surrounding the condition.Provided resources and support groups for patients with pericardial diseases, connecting them with medical information and emotional support networks.

List of Pericardium Diseases Key Companies in the Market

  • Smith and Nephew
  • Teva Pharmaceutical
  • GlaxoSmithKline Plc
  • Novartis AG
  • Eli Lilly and Company
  • Arthrex, Inc.
  • Medtronic
  • Edwards Lifesciences
  • Abbott Laboratories
  • Johnson & Johnson Services
  • R. Bard IncAllergan
  • Integra Lifesciences
  • Livanova
  • Zimmer Biomet